Kristy Ainslie, Ph.D. applies her knowledge base in biomaterials, and immunology to develop new immune-modulatory therapies that treat and prevent infectious, and autoimmune diseases. Her lab aims to design practical and innovative formulations, taking into account the scalable production and applications in developing nations.

Bio-conjugate Chemistry, Confocal Microscopy, Cryo-EM, Drug Formulation, Gene Editing, Cancer, Cardiovascular, Drug Delivery, Exosomes, Gene Therapy, Immunomodulation, Immunotherapy, Nanomedicine, Nanoparticle, Protein Expression, Protein engineering, Tumor Microenvironment

Assay Development, Drug Formulation, HPLC, Computational Modeling, Drug Delivery, Educational Research, PBPK Modeling, Pharmaceutical Policy, Pharmacogenomics, Pharmacokinetics, Pharmacy Practice, Precision Medicine

Assay Development, Bioanalytical Chemistry, Drug Formulation, Drug Quantification, LC-MS/MS, Aging, Cancer, Immunotherapy, Nanomedicine, Nanoparticle, Obesity, Pharmacokinetics, Precision Dosing, Precision Medicine

Animal Models, Bio-conjugate Chemistry, Drug Formulation, HPLC, Physicochemical Characterization, Polymer Synthesis, Blood-brain Barrier, Cancer, Drug Delivery, Nanomedicine, Nanoparticle, Neuroengineering, Opioids, Pediatrics, Structure Activity Relationship, Tumor Microenvironment

Confocal Microscopy, Drug Formulation, Fluorescence Microscopy, Polymer Synthesis, Primary Cell Culture Antibiotics, Bacterial resistance, Drug Delivery, Glioblastoma, Immunomodulation, Immunotherapy, Infectious Diseases, Nanoparticle, Peptide Delivery, Vaccines

Animal Models, Confocal Microscopy, Drug Formulation, Locomotor activity, Primary Cell Culture Cancer, Drug Delivery, Exosomes, Gene Therapy, Immunotherapy, Inflammation, Nanoparticle, Neurodegenerative Diseases, Oxidative Stress, Rare Diseases

Artificial Intelligence, Drug Formulation, Fluorescence Microscopy Drug Delivery, Gene Therapy, HIV, Immunotherapy, Infectious Diseases, Nanomedicine, PBPK Modeling, Respiratory Drug Delivery, Women’s Health